|
Characteristic
|
Negative (N = 771)a
|
Positive (N = 842)a
|
Suspect (N=154)a
|
|---|
|
Age (years)
|
50 (13)
|
61 (14)
|
57 (13)
|
|
Side
| | | |
|
Right
|
373 (48%)
|
383 (45%)
|
71 (46%)
|
|
Left
|
398 (52%)
|
459 (55%)
|
83 (54%)
|
|
Size (mm)
|
15 (37)
|
28 (41)
|
17 (15)
|
|
ACR*
| | | |
|
1
|
4 (1%)
|
1 (0.1%)
|
0 (0%)
|
|
2
|
97 (12.5%)
|
3 (0.4%)
|
0 (0%)
|
|
3
|
440 (57%)
|
13 (1.5%)
|
12 (8%)
|
|
4
|
188 (24.5%)
|
177 (21%)
|
62 (41%)
|
|
5
|
39 (5%)
|
643 (77%)
|
78 (51%)
|
|
Unknown
|
3
|
5
|
2
|
|
Echoguided
|
626 (81%)
|
342 (41%)
|
96 (62%)
|
|
Infiltrating canal carcinoma
|
22 (2.9%)
|
707 (84%)
|
98 (64%)
|
|
Unknown
|
2
|
0
|
0
|
|
Intracanalar carcinoma
|
8 (1.0%)
|
161 (19%)
|
33 (21%)
|
|
Infiltrating lobular carcinoma
|
9 (1.2%)
|
95 (11%)
|
20 (13%)
|
|
Lobular carcinoma in situ
|
5 (0.6%)
|
17 (2.0%)
|
8 (5.2%)
|
|
Disease status
| | | |
|
Benign histology
|
115 (15%)
|
1 (0.1%)
|
31 (20%)
|
|
Malignant histology
|
24 (2.9%)
|
803 (95.5%)
|
120 (78%)
|
|
Benign follow-up
|
471 (61%)
|
0 (0%)
|
1 (0.5%)
|
|
Malignant follow-up
|
1 (0.1%)
|
12 (1.4%)
|
0 (0%)
|
|
Lost to follow-up
|
160 (21%)
|
26 (3%)
|
2 (1.5%)
|
- *FNAC fine needle aspiration cytology, *ACR american college of radiology
- aMean (SD); n (%)
